log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

door Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Gepubliceerd in 2010

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

door Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Gepubliceerd in 2012

Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B(100) in patients with T2DM

door Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Gepubliceerd in 2013

Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids

door Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Gepubliceerd in 2014

The mixed benefit of low lipoprotein(a) in type 2 diabetes

door Hermans, Michel P., Ahn, Sylvie A., Rousseau, Michel F.
Gepubliceerd in Lipids Health Dis (2017)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B(100 )measurement in diabetes: Discriminant Ratio and unbiased equivalence

door Hermans, Michel P, Sacks, Frank M, Ahn, Sylvie A, Rousseau, Michel F
Gepubliceerd in 2011

Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies

door Hermans, Michel P., Bouenizabila, Evariste, Amoussou-guenou, Daniel K., Ahn, Sylvie A., Rousseau, Michel F.
Gepubliceerd in Cardiovasc Diabetol (2015)

1,25-Dihydroxyvitamin D to PTH(1–84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

door Gruson, Damien, Ferracin, Benjamin, Ahn, Sylvie A., Zierold, Claudia, Blocki, Frank, Hawkins, Douglas M., Bonelli, Fabrizio, Rousseau, Michel F.
Gepubliceerd in PLoS One (2015)